SpiceJet In Talks With Aircraft Manufacturers Over Long-Haul Options
Farnborough, England: Airline SpiceJet is in talks with aircraft makers over planes that would help its ambitions to fly long-haul, the carrier's chairman said on Monday.
"We would dearly like to take passengers to Europe and the United States," Ajay Singh, chairman and managing director of SpiceJet, said at an airline panel during the Farnborough Airshow.
"The question is the cost. Can we put enough seats in to get some of the advantages of short-haul low cost? Is there a model out there that we can use?"
"We are exploring that and hope we have some answers soon. We are talking to aircraft manufacturers and let's see if we can build something out," he added.
The rise of low-cost long-haul travelling has been led by Asian carriers such as AirAsia, as well as Norwegian Air Shuttle across the Atlantic, although it remains to be seen whether it can be profitable in the long run.
Gus Kelly, the CEO of Dublin-based lessor AerCap, agreed that one of the big questions with opting for low-cost long-haul was the seating arrangement - namely, whether the airline should invest millions in adding a premium class that they might not be able to sell for a high enough price, or stick to a plane with lots of economy seats.
"Someone will get this right," Mr Kelly said, adding the takeover interest in Norwegian Air Shuttle from IAG was maybe an indication that Norwegian was getting it right.
SpiceJet's Mr Singh said there was a clear place for low-cost long-haul.
"Clearly the market exists from countries like India. In the future, I think this will be the fastest growing market in the world, especially for medium to long-haul," he said.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.